How much BAC water for 10mg tirzepatide — and why this question matters

The decision in front of you: licensed pen or unlicensed powder?

Searching for bacteriostatic water volumes for a specific tirzepatide dose is a practical question, but it reveals a fork in the road. On one side is Mounjaro, manufactured by Eli Lilly, pre-filled, pre-dosed, and approved by the MHRA for weight management in adults. On the other is tirzepatide sold as a raw powder or in vials (typically described as "research grade") which requires reconstitution before injection. The second category is not an authorised medicine in the UK. It has not passed the safety, sterility and potency checks that MHRA approval requires. The MHRA has warned explicitly about fake and unregulated weight-loss injectables circulating online; in October 2025 enforcement teams raided the first illicit UK site manufacturing counterfeit tirzepatide pens. You can read their guidance on the MHRA's Yellow Card site, where suspect products can also be reported.

The reconstitution question itself compounds the risk. Even with genuine pharmaceutical-grade peptides, incorrect BAC water volumes produce inaccurate concentrations. If you are trying to work out how much BAC water to use for a 10 mg tirzepatide vial, for example, the margin for error is real, and getting the volume wrong changes every dose you draw from it, potentially significantly. There is no licensed prescriber overseeing that calculation, no patient information leaflet, and no clinical team to call if something feels wrong. That is the core of the decision: the "cheaper" route carries costs that do not appear on any invoice.

Explore BAC water volumes for other tirzepatide doses if you want to understand how concentration calculations vary, the same licensing and safety concerns apply at every strength.

What private licensed Mounjaro actually costs, and what that price includes

UK private pricing for Mounjaro has shifted considerably. Eli Lilly raised the UK list price from 1 September 2025; the highest-dose pen's list price moved from around £122 to around £330, and private providers have priced accordingly. Typical private monthly costs have been reported in the range of roughly £149–£375 depending on dose and provider, though these figures are hedged, the market moves and individual providers set their own structures.

Those headline numbers sometimes obscure what is and is not included. A low-looking price may exclude the consultation fee, the prescription charge, delivery, or any clinical follow-up if your dose needs reviewing. At nume, we do not run discount codes or promotional offers. The price you see on the Mounjaro pricing page covers consultation, prescription, treatment and free next-working-day delivery by DPD, tracked, in plain unbranded packaging, to your door. We are not trying to win a price comparison. A small monthly saving is not worth much if the clinical oversight is missing.

If you want a broader look at licensed weight-loss treatment options, the weight-loss treatments overview sets out what is currently licensed in the UK and how each option works.

What 'cheap' tirzepatide actually costs

The appeal of unlicensed powders is almost always price. A vial of peptide from an overseas supplier can look dramatically cheaper than a Mounjaro pen. But the cost comparison only holds if both things being compared are equivalent, and they are not. Licensed Mounjaro includes verified potency, sterility, a consistent manufacturing process, and the legal right to prescribe and supply. An unlicensed powder offers none of those assurances.

There are also practical costs people undercount: the BAC water itself, syringes, needles, alcohol swabs, sharps disposal, and the time spent calculating and reconstituting each dose. Questions such as how much BAC water is needed for a 30 mg tirzepatide vial may seem straightforward, but without clinical oversight there is no prescriber adjusting your dose if side effects hit, and no pharmacist to call on a Tuesday evening when something feels off, and the maths changes. The NHS tirzepatide page outlines what proper clinical management of this medicine involves; it is a useful benchmark for what supervised treatment should look like.

On this point, NICE's appraisal of tirzepatide (TA1026) makes the clinical context plain: the recommendation is for use alongside a reduced-calorie diet and increased physical activity, with ongoing clinical review. That wraparound does not come with an unlicensed vial. It does come with a legitimate prescription service.

How the nume consultation works if you want to switch to licensed treatment

If you have been using reconstituted tirzepatide and want to move to licensed Mounjaro, the process at nume is straightforward. You complete a free consultation, our prescribers ask about your current dose, any side effects you have experienced, and your wider health picture. A real clinician reviews that information the same day you submit it. Identity and weight are verified, your GP is notified in line with GPhC guidance, and if the prescriber is satisfied you are suitable, your first pen is dispatched the same day for next-working-day DPD delivery. Order before midday and it tends to arrive before the school run the following afternoon.

Transfer patients are asked to provide evidence of their current treatment and dose, including details such as how much BAC water they have been using for a 60 mg tirzepatide vial, as that step protects you as much as it protects clinical standards. Our clinical team page sets out who is reviewing your case and what their qualifications are. You can also read our FAQs for answers to common questions about switching, eligibility and what to expect.

Suitability for Mounjaro is determined by clinical assessment, not by a checklist: adults with a BMI of 30 or above, or 27 and above with at least one weight-related health condition, may qualify, though the prescriber considers your full picture. Speak to our prescribers to find out whether licensed Mounjaro treatment is right for you.